Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.comThe "Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

The Medical Devices sector report, "Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Transdermal Drug Delivery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Scope of the report:

• Extensive coverage of the Transdermal Drug Delivery Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry.

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Transdermal Drug Delivery Devices Overview

3 Products under Development

3.1 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development

3.2 Transdermal Drug Delivery Devices - Pipeline Products by Segment

3.3 Transdermal Drug Delivery Devices - Pipeline Products by Territory

3.4 Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path

3.5 Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date

3.6 Transdermal Drug Delivery Devices - Ongoing Clinical Trials

4 Transdermal Drug Delivery Devices - Pipeline Products under Development by Companies

4.1 Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development

4.2 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Devices Companies and Product Overview

6 Transdermal Drug Delivery Devices - Recent Developments

6.1 Apr 29, 2019: ChemioCare announces appointment of Roy F. Waldron to its board of directors

6.2 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring

6.3 Apr 25, 2019: The Medicines Company reports first-quarter 2019 financial results and significant progress with the Inclisiran clinical development program

6.4 Apr 25, 2019: DURECT appoints two new board members

6.5 Apr 22, 2019: KalVista Pharmaceuticals names Daniel B. Soland to board of directors

6.6 Apr 19, 2019: Alvogen issues voluntary nationwide recall of Fentanyl Transdermal System due to product mislabeling

6.7 Apr 11, 2019: Sumitomo Dainippon Pharma announces mid-term business plan 2022

6.8 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility

6.9 Apr 09, 2019: Revance appoints former Allergan marketing veteran Taryn Conway as Vice President of marketing

6.10 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors

7 Appendix

Some of the Companies Mentioned include:

• 3M Co
• 4P Therapeutics LLC
• Actuated Medical Inc
• Aequus Pharmaceuticals Inc
• Agile Therapeutics Inc
• Allergan Plc
• Alliqua BioMedical Inc
• AMW GmbH
• AngioSoma Inc
• AstraZeneca Plc
• Avro Life Sciences
• CB Scientific Inc
• Clexio Biosciences Ltd
• Corium International Inc
• Drexel University
• DURECT Corp
• Echo Therapeutics Inc
• Emplicure AB
• Endo International Plc
• Extend Biosciences Inc
• Fe3 Medical Inc
• Georgia Institute of Technology
• Georgia State University
• Intercell AG
• Interstitial NS
• Isis Biopolymer Inc
• Janisys
• Mayne Pharma Group Ltd
• Medherant Ltd
• Medifron DBT Inc
• MEDRx Co Ltd
• MedRx, Inc.
• Nemaura Pharma Ltd
• Noven Pharmaceuticals Inc
• NutriBand Inc
• Nuvo Pharmaceuticals Inc
• Phosphagenics Ltd
• Prometheon Pharma LLC
• Purdue University
• Radius Health Inc
• Scilex Ltd
• Seelos Therapeutics Inc
• Skinject Inc
• Taho Pharmaceuticals Ltd
• Teikoku Pharma USA Inc
• tesa Labtec GmbH
• Teva Pharmaceutical Industries Ltd
• TheraSolve NV
• Theratech, Inc.
• Thrudermic LLC
• Titan Pharmaceuticals Inc
• Toa Eiyo Ltd
• Transdermal Specialties Inc
• TransPharma Medical Ltd
• Transport Pharmaceuticals Inc
• University of Toronto
• ViiV Healthcare UK Ltd
• Vyteris, Inc.
• Xel Pharmaceuticals Inc
• Zambon Italia Srl
• Z-Cube Srl
• ZetrOZ, Inc.
• Zosano Pharma Corp
• Zynerba Pharmaceuticals Inc

For more information about this report visit https://www.researchandmarkets.com/r/yf7cex

View source version on businesswire.com: https://www.businesswire.com/news/home/20190624005800/en/